Reply to Luksic et al. Clin Chem Lab Med 2018;56(4):574–581

Articles in the same Issue

1. Frontmatter
2. Editorial
3. Identification and management of spurious hemolysis: controversies, concerns and criticisms
4. Reviews
5. CYP24A1 and SLC34A1 genetic defects associated with idiopathic infantile hypercalcemia: from genotype to phenotype
6. Meta-analysis: compared with anti-CCP and rheumatoid factor, could anti-MCV be the next biomarker in the rheumatoid arthritis classification criteria?
7. Opinion Paper
8. Collection, transport and storage procedures for blood culture specimens in adult patients: recommendations from a board of Italian experts
9. General Clinical Chemistry and Laboratory Medicine
10. Using the hemoglobin-binding Staphylococcus aureus protein IsdH to enable plasma analysis of hemolyzed blood samples
11. Handling of hemolyzed serum samples in clinical chemistry laboratories: the Nordic hemolysis project
12. Clinical biomarker innovation: when is it worthwhile?
13. Impact of total automation consolidating first-line laboratory tests on diagnostic blood loss
14. Diagnostic and prognostic value of the D-dimer test in emergency department patients: secondary analysis of an observational study
15. Screening of chemical libraries in pursuit of kallikrein-5 specific inhibitors for the treatment of inflammatory dermatoses
16. Comparison of five automated urine sediment analyzers with manual microscopy for accurate identification of urine sediment
17. Establishment of an international autoantibody reference standard for human anti-DFS70 antibodies: proof-of-concept study for a novel Megapool strategy by pooling individual specific sera
18. Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experience
19. Performance evaluation of an Indoxyl Sulfate Assay Kit “NIPRO”
20. Variable and inaccurate serum IgG4 levels resulting from lack of standardization in IgG subclass assay calibration
21. Hematology and Coagulation
22. Influence of hypertriglyceridemia, hyperbilirubinemia and hemolysis on thrombin generation in human plasma
23. Reference Values and Biological Variations
24. Reference intervals for serum total vitamin B12 and holotranscobalamin concentrations and their change points with methylmalonic acid concentration to assess vitamin B12 status during early and mid-pregnancy
25. Cardiovascular Diseases
26. Serum concentrations of free fatty acids are associated with 3-month mortality in acute heart failure patients
27. Letters to the Editor
28. Management of potassium results in haemolysed plasma samples at the emergency department laboratory
29. Unexpected analytical interference in isavuconazole UV determination in a child in therapy with lumacaftor/ivacaftor for cystic fibrosis
30. Total laboratory automation has the potential to be the field of application of artificial intelligence: the cyber-physical system and “Automation 4.0”
31. 99th percentile upper reference limit of AccuTnI+3 in a Korean reference population: a multicenter study using fresh serum
32. Roche Troponin T hs-STAT meets all expert opinion analytical laboratory practice recommendations for the use of the differential diagnosis of acute coronary syndrome
33. A comparison of biotin interference in routine immunoassays on the Roche Cobas 8000, Beckman Coulter DXi and Siemens Advia Centaur XPT immunoassay platforms
34. The importance of the methodology and sample matrix when interpreting chromogranin A results
35. The sudden death of the combined first trimester aneuploidy screening, a single centre experience in Belgium
36. Reply to Luksic et al. Clin Chem Lab Med 2018;56(4):574–581